China Biologic Products Holdings, Inc. Financial Statements 2011-2024 | CBPO

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	4.56 B	4.49 B	2.76 B	2.22 B	3.04 B	3.28 B	1.66 B	763 M	508 M	242 M
Shares	38.7 M	38.7 M	35.3 M	27.4 M	26.8 M	25.6 M	24.4 M	26.4 M	26.2 M	25 M
Net Income	152 M	139 M	128 M	67.9 M	105 M	89 M	70.9 M	54.6 M	45.2 M	18.2 M
Revenue	524 M	504 M	467 M	370 M	341 M	296 M	243 M	203 M	185 M	153 M
EBITDA	223 M	190 M	169 M	149 M	157 M	142 M	119 M	94.4 M	83.4 M	64.6 M
Operating Expenses	149 M	165 M	174 M	109 M	73.2 M	57.4 M	52.1 M	50.9 M	51.5 M	50.1 M
General and Administrative Expenses	83.4 M	73.4 M	68.8 M	67.7 M	54.5 M	41.4 M	32.1 M	36.1 M	34 M	31.5 M